http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-S63258469-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_39ae96c0ecc22ff90ff986371a3cea0f
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y02P20-55
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D277-587
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D213-79
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D209-48
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D501-34
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D501-46
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D277-40
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D501-36
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D209-48
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D213-79
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D277-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D501-24
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D277-38
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D501-20
filingDate 1987-05-29-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_19879c77ebeed9af3dbbcfba0bc081b2
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bbbab02d21b0e2ba3888e78afe273ce5
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6aafd6ef6b1790e2ba12514b2bd48566
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e96c03a4ca67935aa8c937fa6ac9fb84
publicationDate 1988-10-25-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber JP-S63258469-A
titleOfInvention Aminothiazolylacetic acid derivative
abstract NEW MATERIAL:A compound expressed by formula I (R 1 is amino or protected amino; R 2 is cyclo-lower alkenyl) and salts thereof. n EXAMPLE: 2-(2-Cyclopenten-1-yl)oxyimino-2-(2-formamidothiazol-4-yl)acetic acid. n USE: An important intermediate for producing cephem compounds useful as an antimicrobial agent. n PREPARATION: A compound expressed by the formula X-R 2 (X is OH or reactive derivative group thereof) is reacted with a compound expressed by the formula R 6 -OH (R 6 is amino having a protecting group) to provide a compound expressed by the formula R 6 -OR 2 . The amino-protecting group of the above-mentioned compound is then eliminated and the resultant compound is subsequently reacted with a compound expressed by formula II to afford the aimed compound expressed by formula I. n COPYRIGHT: (C)1988,JPO&Japio
priorityDate 1979-09-03-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID20498196
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226420393
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID234740605
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458396401
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID53822872
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID234880867
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID420966385
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID420512799
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID18635708
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID20836467
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID12784495
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226420394

Total number of triples: 38.